author-photo

Charlotte L. Rawcliffe

University of Liverpool

22

Papers

2500

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (53)
Biomarker predication of efficacy to gemcitabine plus vandetanib in phase II, double blind multicentre randomised controlled trial of gemcitabine placebo in locally advanced or metastatic pancreatic carcinoma

2018 Pancreatology
Show All
- Source
- Cite
- Save
Citations (1)
788TiPACELARATE: A randomised phase III, open label, clinical study comparing NUC-1031 with gemcitabine in patients with metastatic pancreatic carcinoma

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
HENT1 tumor levels to predict survival of pancreatic ductal adenocarcinoma patients who received adjuvant gemcitabine and adjuvant 5FU on the ESPAC trials.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (14)
Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo-controlled trial in locally advanced or metastatic pancreatic carcinoma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial

2017 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (38)
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer.

2016 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (26)
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma

2016 Pancreatology
Show All
- Source
- Cite
- Save
Citations (0)
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial

2014 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (291)
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial

2012 JAMA
Show All
- Source
- Cite
- Save
Citations (388)